Additionally, global Gdf10 knockout does not result in any discernible effects on tissue development.[7] Thus, GDF10 could be an HSC‐specific drug target for liver fibrosis, as it mainly inhibits TGF‐β signaling in HSCs but not in other cells. The gene discussed is GDF10; the disease is Hepatic fibrosis.